For example, programmed death-ligand 1 (PD-L1) can engage programmed cell death protein 1 (PD-1) on T cells to induce their functional exhaustion, and therefore ICB offers a powerful tool to unleash suppressed anti-tumour immune responses in patients [6]. Here, PDCD1 is linked to neoplasm.